Gebhart P

ORCID: 0000-0002-0657-2750 · 1 paper in corpus
2023
BMC cancer ·doi:10.1186/s12885-023-11116-6

BackgroundOvarian cancer screening in BRCA1/2 mutation carriers utilizes assessment of carbohydrate antigen 125 (CA125) and transvaginal ultrasound (TVU), despite low sensitivity and specificity. We evaluated the association between CA125 l…